Phase 1 trial of preoperative, short-course carbon-ion radiotherapy for patients with resectable pancreatic cancer (Q84491970)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22744973%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Phase 1 trial of preoperative, short-course carbon-ion radiotherapy for patients with resectable pancreatic cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22744973%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

main subject

phase I clinical trial

1 reference

1 reference

6

Hiroshi Honda

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22744973%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

5

Yoshiyuki Shioyama

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22744973%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Makoto Shinoto

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22744973%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Shigeru Yamada

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22744973%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Shigeo Yasuda

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22744973%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Hiroshi Imada

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22744973%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Tadashi Kamada

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22744973%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Hirohiko Tsujii

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22744973%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Hiromitsu Saisho

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22744973%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Working Group for Pancreas Cancer

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22744973%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

28 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22744973%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

number of pages

7

1 reference

inferred from page(s)

published in

Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22744973%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22744973%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22744973%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

45-51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22744973%20AND%20SRC:MED&resulttype=core&format=json

Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project

6 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27723

7 January 2021

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27723

7 January 2021

Prognostic indicators for survival after resection of pancreatic adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27723

7 January 2021

A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27723

7 January 2021

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27723

7 January 2021

EBM-based Clinical Guidelines for Pancreatic Cancer 2009 from the Japan Pancreas Society: a synopsis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27723

7 January 2021

Phase I study of preoperative short-course chemoradiation with proton beam therapy and capecitabine for resectable pancreatic ductal adenocarcinoma of the head

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27723

7 January 2021

Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: analysis of histopathology and outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27723

7 January 2021

Assessment of pathologic response after preoperative chemoradiotherapy and surgery in pancreatic adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27723

7 January 2021

Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27723

7 January 2021

Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27723

7 January 2021

Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27723

7 January 2021

Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27723

7 January 2021

Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27723

7 January 2021

Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27723

7 January 2021

Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27723

7 January 2021

A pilot study of preoperative chemoradiation for patients with localized adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27723

7 January 2021

Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27723

7 January 2021

Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27723

7 January 2021

Preoperative chemoradiation in potentially resectable pancreatic adenocarcinoma: feasibility, treatment effect evaluation and prognostic factors, analysis of the SFRO-FFCD 9704 trial and literature review.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27723

7 January 2021

Effects of neoadjuvant combined chemotherapy and radiation therapy on the CT evaluation of resectability and staging in patients with pancreatic head cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27723

7 January 2021

Identifiers

DOI

10.1002/CNCR.27723

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22744973%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference